College ter Beoordeling van Geneesmiddelen — Tekorten (CBG-MEB)
College ter Beoordeling van Geneesmiddelen — Tekorten is the official source of medicine shortage information for Netherlands (EU). Mederti checks its register daily and links every notice back to the original publication.
- Official register
- www.cbg-meb.nl
- Country
- Netherlands
- Notices tracked by Mederti
- 1,876
- Last checked
- 2 Aug 2026
Latest notices from CBG-MEB
- Letrozol — active, medium, since 31 Jul 2026 (source)
- Pantoprazol — active, medium, since 31 Jul 2026 (source)
- Dinoproston — active, medium, since 31 Jul 2026 (source)
- Quetiapine — active, medium, since 31 Jul 2026 (source)
- Folinezuur — active, medium, since 31 Jul 2026 (source)
- Rifabutine — active, medium, since 31 Jul 2026 (source)
- Choriongonadotrofine — active, medium, since 31 Jul 2026 (source)
- Ipratropium — active, medium, since 31 Jul 2026 (source)
- Captopril — active, medium, since 31 Jul 2026 (source)
- Diclofenac — active, medium, since 31 Jul 2026 (source)
- Midazolam — active, medium, since 31 Jul 2026 (source)
- Retinol — active, medium, since 31 Jul 2026 (source)
- Fenobarbital — active, medium, since 31 Jul 2026 (source)
- Ondansetron — active, medium, since 31 Jul 2026 (source)
- Hepatitis-A-Vaccin/ Hepatitis-B-Vaccin — active, high, since 31 Jul 2026 (source)
Every CBG-MEB notice, searchable and alertable
Search Netherlands's full register alongside 50+ other countries — free for individual pharmacists and clinicians.
Create a free accountMederti is not affiliated with or endorsed by College ter Beoordeling van Geneesmiddelen — Tekorten. All notices remain the property of their publisher and are linked to the original source.